Specific inhibition of coxsackievirus B3 translation and replication by phosphorothioate antisense oligodeoxynucleotides

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 4, 2001, Pages 1043-1052

  Wang, A ^a   Cheung, P K M ^a   Zhang, H ^a   Carthy, C M ^a   Bohunek, L ^a   Wilson, J E ^a   McManus, B M ^a   Yang, D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; LIPOFECTIN; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANTIVIRAL ACTIVITY; ARTICLE; COXSACKIE VIRUS B3; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS PLAQUE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ENTEROVIRUS B, HUMAN; HELA CELLS; HUMANS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PLAQUE ASSAY; PROTEIN BIOSYNTHESIS; RNA, VIRAL; THIONUCLEOTIDES; TRANSFECTION; UNTRANSLATED REGIONS; VIRAL STRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 0035087431     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.4.1043-1052.2001     Document Type: Article

References (54)

1. Betacyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence
2. Inhibition of influenza virus replication by phosphorothioate and liposomally encapsulated oligonucleotides
3. Viral myocarditis and its sequelae
4. Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides
5. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides
6. Sequences within the poliovirus internal ribosome entry segment control viral RNA synthesis
7. Progress in antisense oligonucleotide therapeutics
8. Higher structures of coxsackievirus B3 5′ nontranslated region RNA
9. In vitro translation of poliovirus RNA: Utilization of internal initiation sites in reticulocyte lysate
10. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: Location to the 5′ nontranslated region
11. FDA approves first antisense drug for CMV retinitis
12. The cap and poly (A) tail function synergistically to regulate messenger RNA translational efficiency
13. Phosphorothioate oligonudeotides are inhibitors of human DNA polymerases and RNase H: Implications for antisense technology
14. Epidemiology of viral infections of the heart
15. Minimum internal ribosomal entry site required for poliovirus infectivity
16. pro with the 5′ and 3′ termini of the poliovirus genome. Identification of viral and cellular cofactors needed for efficient binding
17. Inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by unmodified, phosphorothioated and liposomally encapsulated oligonucleotides
18. Translation control in mammalian cells
19. The registry of the International Society for Heart and Lung Transplantation: Eleventh official report - 1994
20. The novel mechanism of initiation of picornavirus RNA translation
21. Initiation of protein synthesis by internal entry of ribosomes into the 5′ nontranslated region of encephalomyocarditis virus RNA in vivo
22. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation
23. Dilated cardiomyopathy in the adult
24. Liposomes as a drug delivery system for antisense oligonucleotides
25. Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: Two initial 5′ uridine residues are regained during plus-strand RNA synthesis
26. The scanning model for translation: An update
27. Viral proteinases
28. Contributions of the brome mosaic virus RNA-3 3′-nontranslated region to replication and translation
29. Cellular factors in the transcription and replication of viral RNA genomes: A parallel to DNA dependent RNA transcription
30. A phylogenetically conserved sequence within viral 3′ untranslated RNA pseudoknots regulates translation
31. The genome linked protein of picornaviruses: A protein covalently linked to poliovirus genome RNA
32. Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: An in vitro model for treatment
33. Structural and functional analysis of the 5′ untranslated region of coxsackievirus B3 RNA: In vivo translational and infectivity studies of full-length mutants
34. Myocarditis: Evolving concepts of cause, consequence, and control
35. Kissing of the two predominant hairpin loops in the coxsackie B virus 3′ untranslated region is the essential structural feature of the origin of replication required for negative-strand RNA synthesis
36. Binding of a cellular factor to the 3′ untranslated region of the RNA genomes of entero- and rhinoviruses plays a role in virus replication
37. An RNA tertiary structure in the 3′ untranslated region of enteroviruses is necessary for efficient replication
38. In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides
39. In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides
40. Potent inhibition of respiratory syncytial virus replication using a 2-5A-antisense chimera targeted to signals within the virus genomic RNA
41. The 3′ untranslated region of picornavirus RNA: Features required for efficient genome replication
42. Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5′ nontranslated RNA of hepatitis A virus
43. Dose antisense exist?
44. Antisense oligonucleotides as therapeutic agents - Is the bullet really magical?
45. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxyribonucleotides
46. Association of the yeast poly (A) tail binding protein with translation initiation factor eIF4G
47. BCR-ABL antisense oligodeoxyribonucleotides suppress the growth of leukemic and normal hematopoietic cells by a sequence specific but nonantisense mechanism
48. The state of art in antisense research
49. Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides
50. Structural requirements of the higher order RNA kissing element in the enteroviral 3′ UTR
51. Circulization of mRNA by eukaryotic translational initiation factors
52. Encephalomyocarditis virus internal ribosomal entry site RNA-protein interactions
53. pro of poliovirus is essential for RNA replication
54. In vitro mutational and inhibitory analysis of the cis-acting translational elements within the 5′ untranslated region of coxsackievirus B3: Potential targets for antiviral action of antisense oligomers